Title : Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts.

Pub. Date : 2013 Sep

PMID : 24023287






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIM: The objective of the present study was to determine the in vivo antitumor activity of elacytarabine, the 5"-elaidic acid ester of arabinofuranosyl cytidine, alone and in combination with bevacizumab, cetuximab and trastuzumab in Vascular endothelial growth factor (VEGF), Epidermal growth factor receptor (EGFR)- and Human epidermal growth factor receptor 2 (HER2)-expressing non-small cell lung cancer xenografts. 5'-oleoyl cytarabine erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 AIM: The objective of the present study was to determine the in vivo antitumor activity of elacytarabine, the 5"-elaidic acid ester of arabinofuranosyl cytidine, alone and in combination with bevacizumab, cetuximab and trastuzumab in Vascular endothelial growth factor (VEGF), Epidermal growth factor receptor (EGFR)- and Human epidermal growth factor receptor 2 (HER2)-expressing non-small cell lung cancer xenografts. 5'-oleoyl cytarabine erb-b2 receptor tyrosine kinase 2 Homo sapiens